Company Description

Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.

The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona.

Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.

Picard Medical, Inc.

Country	United States
Founded	1981
IPO Date	Aug 29, 2025
Industry	Medical Devices
Sector	Healthcare
Employees	75
CEO	Patrick Schnegelsberg

Contact Details

Address: 1992 E Silverlake Road Tucson, Arizona 85713 United States
Phone	520 545 1234
Website	syncardia.com

Stock Details

Ticker Symbol	PMI
Exchange	NYSEAMERICAN
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$4.00
CIK Code	2030617
CUSIP Number	71953R108
ISIN Number	US71953R1086
SIC Code	3841

Key Executives

Name	Position
Patrick N. J. Schnegelsberg	Chief Executive Officer and Director
Bernard Skaggs	Chief Financial Officer
Matthew Schuster	Chief Operating Officer
Dr. Frank Tinker Ph.D.	Chief Technology Officer of SynCardia Systems, LLC

Latest SEC Filings

Date	Type	Title
Feb 26, 2026	8-K	Current Report
Feb 19, 2026	DEFR14A	Filing
Feb 19, 2026	DEF 14A	Other definitive proxy statements
Feb 11, 2026	SCHEDULE 13G	Filing
Feb 10, 2026	PRE 14A	Other preliminary proxy statements
Feb 10, 2026	424B3	Prospectus
Feb 6, 2026	EFFECT	Notice of Effectiveness
Feb 4, 2026	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Jan 27, 2026	S-8	Securities to be offered to employees in employee benefit plans
Jan 13, 2026	8-K	Current Report

View All SEC Filings